ASP2713

· Astellas Pharma Global Development, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ASP2713, covering 2024-10-16 to 2024-10-16. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess ASP2713 in Healthy Subjects [Phase 1]